Time to treatment failure following initiation of fingolimod versus teriflunomide for multiple sclerosis: a retrospective U.S. claims study

Maria Cecilia Vieira,Devon S. Conway,Gina Mavrikis Cox,Miranda Peeples,Arielle G. Bensimon,Monica Macheca,Vivian Herrera

Time to treatment failure following initiation of fingolimod versus teriflunomide for multiple sclerosis: a retrospective U.S. claims study

2019

Maria Cecilia Vieira
Devon S. Conway
Gina Mavrikis Cox
Miranda Peeples
Arielle G. Bensimon
Monica Macheca
Vivian Herrera

AbstractObjective: Disease modifying therapies (DMTs) for multiple sclerosis (MS) aim to delay progression and reduce relapses. Evidence is limited on the comparative effectiveness of the oral DMTs...

Keywords:

Diabetes mellitus
Multiple sclerosis
Fingolimod
Teriflunomide
Medicine
Anesthesia
Internal medicine
Disease
treatment failure
time to treatment failure

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations